Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.
Accelerating clinical development of a live attenuated vaccine against Salmonella Paratyphi A (VASP): study protocol for an observer-participant-blind randomised control trial of a novel oral vaccine using a human challenge model of Salmonella Paratyphi A infection in healthy adult volunteers.
McCann N. et al, (2023), BMJ Open, 13
ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface
Zhang P. et al, (2023)
Accelerated waning of the humoral response to COVID-19 vaccines in obesity.
van der Klaauw AA. et al, (2023), Nat Med
An assessment of the downstream implications of blood culture collection and transit
Davies PJB. et al, (2023), European Journal of Clinical Microbiology & Infectious Diseases
Cryogenic electron ptychographic single particle analysis with wide bandwidth information transfer.
Pei X. et al, (2023), Nature communications, 14
Defining the key intrahepatic gene networks in HCV infection driven by sex
Marchi E. et al, (2023), Gut, 72, 984 - 994
Disparities in care and outcomes for primary liver cancer in England during 2008-2018: a cohort study of 8.52 million primary care population using the QResearch database.
Liao W. et al, (2023), EClinicalMedicine, 59
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Abani O. et al, (2023), The Lancet, 401, 1499 - 1507
Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines.
Dold C. et al, (2023), Vaccine, 41, 3047 - 3057
Investigation of the milling characteristics of different focused-ion-beam sources assessed by three-dimensional electron diffraction from crystal lamellae.
Parkhurst JM. et al, (2023), IUCrJ
Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK.
Wei J. et al, (2023), Nature communications, 14
Dynamic mitochondrial transcription and translation in B cells control germinal center entry and lymphomagenesis.
Yazicioglu YF. et al, (2023), Nat Immunol
Neutrophils and emergency granulopoiesis drive immune suppression and an extreme response endotype during sepsis.
Kwok AJ. et al, (2023), Nat Immunol
Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial
Hamaluba M. et al, (2023), Wellcome Open Research, 8, 182 - 182
Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccination.
Yin Z. et al, (2023), Cell Rep, 42
COVID-19 vaccine effectiveness and variants in Nepal: study protocol for a test-negative case-control study with SARS-CoV-2 genetic sequencing.
Bijukchhe SM. et al, (2023), BMJ Open, 13
Optimising the timing of whooping cough immunisation in mums (OpTIMUM) through investigating pertussis vaccination in pregnancy: an open-label, equivalence, randomised controlled trial.
Calvert A. et al, (2023), Lancet Microbe
Immune responses in children after vaccination with a typhoid Vi-tetanus toxoid conjugate vaccine in Bangladesh.
Khanam F. et al, (2023), Vaccine